In summary, our findings demonstrate a protumorigenic function of IL-1β in PDGFB-driven mGBM and show that blocking IL-1β signaling decreases inflammatory monocyte recruitment, MG abundance, and the frequency of exhausted CD8+ T cells, prolonging survival of tumor-bearing mice. The gene discussed is CD8A; the disease is neoplasm.